New pneumococcal vaccine for babies around 2 months old
Part of Infections clinical trials.
This trial tests a new pneumococcal vaccine for babies around 2 months old. It aims to prevent serious infections like pneumonia and meningitis, and may offer protection against more strains than current vaccines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 42 and 89 days old (about 6 to 14 weeks).
- Your baby must be born at full term (at least 37 weeks of pregnancy).
- Your baby has not received certain vaccines yet, including pneumococcal, DTaP, Hib, or more than one dose of hepatitis B.
- Your baby must be generally healthy, without serious chronic conditions or immune problems.
- Your baby must not have a fever (under 37.5°C) on the day of vaccination.
- You must have your baby's vaccination records since birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pneumonia vaccine in healthy children to see if it is safe and works well. It may help protect your child from serious infections caused by the bacteria that lead to pneumonia.
This study tests a new pneumococcal vaccine (PCV24) for babies ages 2 to 23 months. It aims to see if the vaccine is safe and helps protect against serious infections like pneumonia and meningitis.
This trial tests a 13-valent pneumococcal conjugate vaccine to prevent pneumonia and serious infections caused by pneumococcus bacteria. It may be a good option if your child has never had a pneumococcal vaccine before.
This trial tests a new pneumococcal vaccine (PCV24) in healthy infants and children. It aims to protect against serious infections like pneumonia and meningitis caused by pneumococcal bacteria.
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
Hear when a new Pneumococcal Infectious Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.